2025-12-23 - Analysis Report
Okay, here's a comprehensive analysis of Salesforce (CRM) based on the provided data, broken down into sections for clarity.

**1) Return Rate Comparison**

*   **CRM Overview:** Salesforce Inc. is a global leader in cloud-based software, providing customer relationship management (CRM) services and related applications.
*   **CRM Cumulative Return:** -4.11%
*   **S&P 500 (VOO) Cumulative Return:** 100.88%
*   **Divergence:**
    *   Current Divergence: -105.0
    *   Relative Divergence: 7.0 (meaning it's near the bottom of its historical divergence range)

**Analysis:** CRM has significantly underperformed the S&P 500 over the specified period.  The negative divergence indicates substantial underperformance relative to the overall market, placing it near the lower end of its historical underperformance range compared to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR  | MDD   | Alpha | Beta | Cap(B) |
|------------|-------|-------|-------|------|--------|
| 2015-2017  | 39.0% | 70.6% | 10.0% | -0.0 | 99.1   |
| 2016-2018  | 34.0% | 73.5% | 19.0% | 0.1 | 132.8  |
| 2017-2019  | 22.0% | 73.5% | 0.0%  | 0.4 | 157.7  |
| 2018-2020  | 14.0% | 73.5% | -10.0% | 0.4 | 215.7  |
| 2019-2021  | 37.0% | 71.9% | -10.0% | 0.7 | 246.3  |
| 2020-2022  | -78.0% | 74.7% | -78.0% | 0.4 | 128.5  |
| 2021-2023  | -47.0% | 76.6% | -49.0% | -0.6 | 255.1  |
| 2022-2024  | -42.0% | 76.6% | -63.0% | -0.4 | 324.1  |
| 2023-2025  | 7.0%  | 76.6% | -58.0% | -2.1 | 251.9  |

*   **CAGR:** The Compound Annual Growth Rate has fluctuated significantly, with strong performance in earlier periods and negative growth in more recent years.
*   **MDD:** The Maximum Drawdown is consistently high, indicating substantial volatility and potential for significant losses.
*   **Alpha:** Alpha is largely negative in recent periods, meaning the stock is underperforming relative to its expected return based on its risk (Beta).
*   **Beta:** Beta has been quite volatile, from negative values to high positive values.
*   **Cap(B):** Market Cap is volatile, decreasing dramatically in recent periods.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 259.91
*   **Last Market Data:** Price: 264.63, Previous Close: 259.91, Change: 1.82
*   **5-day SMA:** 257.08
*   **20-day SMA:** 248.59
*   **60-day SMA:** 246.25

**Analysis:** The stock price is currently above all its moving averages, suggesting a short-term upward trend. The recent market data shows a positive change, indicating potential upward momentum.

**3) Indicator Analysis**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommended)
*   **RSI:** 75.66 (Overbought)
*   **PPO:** 0.35
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (4 shares - Safe - MRI:0.80) (Cash Ratio: 0% on 2025-12-02)
*   **Recent (20 days) relative divergence change:** -0.6 (Short-term decline)
*   **Expected Return (%):** -639.9 (Very negative long-term outlook compared to S&P 500)

**Analysis:** The RSI indicates the stock is overbought, suggesting a potential pullback. The PPO is relatively low. The MRI suggests a medium level of investment risk. The "Hybrid Signal" indicates a "Buy" recommendation (although the negative expected return significantly contrasts this suggestion). Recent divergence change suggests short-term downward pressure.  The extremely negative Expected Return suggests significant concerns about long-term investment prospects.

**4) Recent News & Significant Events**

*   **Morgan Stanley Reduces Price Target:** Suggests potential headwinds.
*   **Salesforce & AI:** Mixed views on Salesforce's leadership in AI. Some argue they aren't a leader, while others see potential for success.
*   **Earnings Good Enough to End Losing Streak:** Indicates recent positive momentum related to earnings reports.
*   **Microsoft & Salesforce as Top Software Stocks (Evercore):** Positive outlook from one analyst firm for the long term.
*   **Can Salesforce Stock Recover?:** Reflects ongoing market uncertainty about the stock's future performance.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean of 1.64)
*   **Target Price:** Average $330.06 (Significant upside potential from current price)

**Analysis:** Analyst opinions are generally positive, with a "Buy" consensus and a significant upside potential implied by the average target price. However, the recent price target reduction from Morgan Stanley indicates potential caution.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출    |
|------------|------|---------|
| 2025-12-04 | 2.2  | 10.26 B$|
| 2025-09-04 | 1.97 | 10.24 B$|
| 2025-05-29 | 1.61 | 9.83 B$ |
| 2024-12-04 | 1.6  | 9.44 B$ |
| 2025-12-04 | 1.6  | 9.44 B$ |

**Analysis:** Earnings per share (EPS) and revenue have generally been increasing over the last few quarters, indicating positive financial performance. The latest quarter (2025-12-04) shows a significant jump in EPS.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue     | Profit Margin |
|--------------|-------------|---------------|
| 2025-10-31   | $10.26B     | 78.02%        |
| 2025-07-31   | $10.24B     | 78.10%        |
| 2025-04-30   | $9.83B      | 76.96%        |
| 2025-01-31   | $9.99B      | 77.81%        |
| 2024-10-31   | $9.44B      | 77.71%        |

**Capital and Profitability:**

| Quarter      | Equity      | ROE    |
|--------------|-------------|--------|
| 2025-10-31   | $60.02B     | 3.48%  |
| 2025-07-31   | $61.33B     | 3.08%  |
| 2025-04-30   | $60.67B     | 2.54%  |
| 2025-01-31   | $61.17B     | 2.79%  |
| 2024-10-31   | $58.52B     | 2.61%  |

**Analysis:** Revenue is consistently growing. Profit margins are very high and relatively stable. Return on Equity (ROE) has improved in the most recent quarter, but is still relatively modest.

**7) Comprehensive Analysis**

*   **Contradictory Signals:**  There are several conflicting signals.  Recent earnings and revenue growth, high profit margins, and positive analyst consensus point to potential upside. However, the negative divergence from the S&P 500, overbought RSI, negative alpha in recent periods, short-term declining divergence, very negative expected return compared to S&P 500, and the high maximum drawdown suggest caution.
*   **Growth vs. Market Sentiment:**  While Salesforce continues to show revenue growth and healthy profitability, market sentiment seems to be weighing on the stock's performance.
*   **AI and Future Outlook:** The news articles highlight some uncertainty about Salesforce's position in the AI space, which is a critical growth area for the tech sector.
*   **Overall:**  Salesforce is a fundamentally sound company with increasing revenue and high-profit margins. It is currently experiencing short-term positive momentum. However, there are significant risks and uncertainties, reflected in the very negative expected return compared to the S&P 500 and high historical volatility. Investors should carefully consider their risk tolerance and conduct further research before making an investment decision. The discrepancy between analyst target prices and the stock's current performance indicates that the market may be pricing in significant risks not fully captured by the analysts' estimates.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.